The weekly litigation news digest is live. Subscribe now

IP Verse

Capsule Formulations - EP4233850

The patent EP4233850 was granted to Chemocentryx on Oct 2, 2024. The application was filed on Nov 27, 2019 under application number EP23160271A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4233850

CHEMOCENTRYX
Application Number
EP23160271A
Filing Date
Nov 27, 2019
Status
Granted And Under Opposition
Aug 30, 2024
Publication Date
Oct 2, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LEK PHARMACEUTICALS DDJun 12, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP2381778
OPPOSITIONUS2007298099
OPPOSITIONUS2010311753
OPPOSITIONUS2011086844
OPPOSITIONUS2013312973
OPPOSITIONUS2016346207
OPPOSITIONUS2017246186
OPPOSITIONUS2018179160
OPPOSITIONUS2018280530
OPPOSITIONUS8632763
OPPOSITIONWO2011163640
OPPOSITIONWO2017123716
OPPOSITIONWO2019089534
OTHEREP2381778
OTHERUS2011086844
OTHERWO2017123716
OTHERWO2019089534
SEARCHUS2018179160

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents